Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Noteable


T.ONC

RE:RE:RE:RE:RE:RE:Gap Open @ C$ 1.86

By ONCY beginning the process of enrolling between 180-200 patients in a...

August 13, 2024

T.ONC

RE:RE:RE:RE:RE:Gap Open @ C$ 1.86

Lottsa room for one or two with 2 and potentially 3 registration studies now...

August 13, 2024

T.ONC

RE:RE:RE:Gap Open @ C$ 1.86

Whacha still doin' here boss?? You and Quentin were long gone boyz. lol !...

August 13, 2024

T.ONC

RE:RE:Gap Open @ C$ 1.86

Yez boss. LOL!!

August 13, 2024

T.ONC

Gap Open @ C$ 1.86

followed by another at C$3.70 with warrants expirng tomorrow.

August 13, 2024

T.ONC

RE:Open Gap at US $1.36

Correction US$1.81

August 13, 2024

T.ONC

Open Gap at US $1.36

Approximately 3.5 Million warrants expiring tomorrow.

August 13, 2024

T.ONC

Gap Closed

Warrants expiring tomorow.

August 13, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

I wonder if "he" knew that Celine's song 'My Heart Will Go...

August 10, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

Iovance is pricing their TiLs treatment at a wholesale acquisition cost of...

August 10, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

Should read " ...led to both drugs being approved through the FDA's...

August 10, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

  March 5, 2024 , by Carmen Phillips   FDA...

August 10, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

The information that I post is related, like ONCY's planned mBC...

August 10, 2024

T.ONC

RE:ONCY Q2-2024 earnings call Pelareorep as a backbone therapy

At the latest earnings call Tom Heineman commented on ONCY's mBC...

August 10, 2024

T.ONC

RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals

According to RBC analysts they are expectig Big Pharma to implement their M...

August 10, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

December 2023 - Poster at SABCS T Cell Receptor Sequencing to Monitor...

August 10, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

ESMO 2022 - Poster - Results from Aware-1  https://oncolyticsbiotech...

August 10, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

CD8+ TiL cells are critical mediators of cytotoxic effector function in...

August 10, 2024

T.ONC

ONCY Q2-2024 earnings call Pelareorep as a backbone therapy

Tom Heineman: " ...We presented an abstract detailing pela's ability...

August 10, 2024

T.ONC

RE:ONCY pelareorep + ICI in metastatic colorectal cancer (mCRC)

August 08, 2024 - GSK's immune checkpoint inhibitor (ICI) drug ...

August 8, 2024

Featured Company